Ignite Creation Date:
2024-05-06 @ 1:04 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03927534
Status:
COMPLETED
Last Update Posted:
2021-02-23
First Post:
2019-04-19
Brief Title:
Efficacy of a Mindful-eating Program to Reduce Emotional Eating
Sponsor:
Hospital Miguel Servet
Organization:
Hospital Miguel Servet
Study Overview
Official Title:
Efficacy of a Mindful Eating Program to Reduce Emotional Eating in Patients Suffering From Overweight or Obesity in Primary Care Settings a Cluster Randomized Controlled Clinical Trial Protocol
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Mindfulness-Based Interventions have been applied in different fields to improve physical and psychological health However little is known about its applicability and effectiveness in Spanish adults with overweight and obesity The aim of the present study protocol is to evaluate the feasibility and efficacy of an adapted MBI programme to reduce emotional eating in adults with overweight and obesity in primary care PC settings
Detailed Description:
This study is a multi-centre two-armed randomized controlled trial RCT with pre-treatment post-treatment and 1-year follow-up measures and a 11 allocation rate between groups Patients from four mental health units in Zaragoza Spain will be randomly assigned to two different parallel conditions with one psychological intervention group ME TAU and usual treatment TAU alone managed by their general practitioner GP to test the superiority of ME TAU provision compared with TAU alone provision For ethical reasons those patients allocated to TAU alone will be offered the ME programme after finishing the trial at 1-year follow-up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None